Search for Clinical Trial Results
AIDS-Related Opportunistic Infections - 154 Studies Found
| Status | Study |
| Completed |
Study Name: When to Start Anti-HIV Drugs in Patients With Opportunistic Infections Condition:
Date: 2003-02-19 Interventions:
|
| Not yet recruiting |
Study Name: Cryptococcal Antigen Screening Plus Sertraline Condition:
|
| Completed |
Study Name: Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity Condition: Kaposi´s Sarcoma Date: 2011-02-15 Interventions: Drug: Bevacizumab Intralesional bevacizumab, dosis of 5mg/cm2, injections every 2 weeks, total number of |
| Completed |
Study Name: Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma Condition:
Date: 2010-01-26 Interventions: Drug: Lenalidomide Lenalidomide is administered daily on days 1-21 of a 28-day cycle. The maximum durati |
| Completed |
Study Name: Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma Condition:
Date: 2007-03-01 Interventions: Drug: interleukin-12 |
| Completed |
Study Name: Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma Condition: AIDS-related Kaposi Sarcoma Date: 1999-11-01 Interventions:
|
| Withdrawn |
Study Name: Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma Condition:
|
| Active, not recruiting |
Study Name: Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Condition:
|
| Completed |
Study Name: AIDS and Cancer Specimen Bank (ACSB) Condition:
|
| Completed |
Study Name: A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma Condition:
Date: 1999-11-02 Interventions: Drug: TNP-470 |